热门资讯> 正文

ReShape Lifesciences重新获得纳斯达克合规

2025-06-27 21:53

ReShape Lifesciences (NASDAQ:RSLS) has regained compliance with Nasdaq requiring at least $2.5M in stockholders’ equity.
Source: Press release

More on ReShape Lifesciences

ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)
Financial information for ReShape Lifesciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。